Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Natural History vs. Registry Studies in Rare Disease By Angi Robinson April 12, 2017 Clinical ResearchPhase 1 - Phase 4 Want to Study Rare Disease? Get Ready for These Roadblocks By Angi Robinson January 12, 2017 Clinical ResearchPhase 1 - Phase 4 Rare Disease Research: 3 Biggest Hang-Ups to Patient Recruitment By Angi Robinson January 5, 2017 Patient and Stakeholder Engagement Tales from the Road – World Congress Patient Advocacy Summit By Angi Robinson December 23, 2016 Clinical ResearchPhase 1 - Phase 4 Getting It Right from the Start: Applying QbD to Rare Disease Studies By Angi Robinson August 23, 2016 Previous 1 2 × ALSO OF INTERESTRare Disease and Pediatrics Expert to Address...Planning Rare Disease Studies: Our Top Expert...Premier Voices #2: Registry Studies & Natural...
